Controlling hypertension and reducing its associated morbidity and mortality in the Caribbean: implications of race and ethnicity
- PMID: 28752658
- PMCID: PMC8031197
- DOI: 10.1111/jch.13056
Controlling hypertension and reducing its associated morbidity and mortality in the Caribbean: implications of race and ethnicity
Abstract
Cardiovascular diseases and stroke, especially hypertension, represent a significant global disease burden for both morbidity and mortality, with a disproportionately higher impact in vulnerable low- to middle-income countries. International initiatives such as the Centers for Disease and Prevention and the Pan American Health Organization Standardized Hypertension Treatment Project have been developed to address this burden on the Caribbean and Latin America populations. The disparity in disease burden observed in low- to middle-income countries is explained, in part, by differences in disease risks for different racial and ethnic groups with high blood pressure more prevalent and hypertension-related morbidity significantly higher in men and women of African heritage. In addition to the race and ethnic differences in indicators of socioeconomic status, access to care and health service delivery, the physiologic mechanism of high blood pressure including salt-sensitivity, may also play a significant role in the disparities in hypertension and hypertension-related outcomes. This article focuses on potential racial and ethnic differences in influences on the pathophysiology of hypertension in the Caribbean region of the world. The identification of such differences may be used in the development of population hypertension control strategies and treatment approach that address the excess disease burden in these populations. The consideration of strategies, such as salt reduction and hypertension awareness and treatment, are particularly relevant to the high-risk Caribbean region.
©2017 Wiley Periodicals, Inc.
References
-
- WHO . Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization; 2013.
-
- Zhang XH, Lisheng L, Campbell NR, Niebylski ML, Nilsson P, Lackland DT. Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low‐Resource Settings: a Policy Statement From the World Hypertension League. J Clin Hypertens (Greenwich). 2016;18:5‐6. - PMC - PubMed
-
- CDC . Global Standardized Hypertension Treatment Project: identification of a core set of medications & care delivery models for the medical treatment of hypertension. Atlanta, GA: Centers for Disease Control and Prevention; 2013. http://www.cdc.gov/globalhealth/ncd/pdf/GSHTPp_march2013.pdf. Accessed March 7, 2016.
-
- Rodriguez F, Ferdinand KC. Hypertension in minority populations: new guidelines and emerging concepts. Adv Chronic Kidney Dis. 2015;22:145‐153. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
